VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update
— Completion of vaccination and enrollment in Sci-B-Vac® PROTECT and CONSTANT Phase 3 studies, respectively — — Encouraging early […]
CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology
–CRISPR Therapeutics Gains Additional Rights to MaxCyte’s Cell Engineering Technology to Develop CRISPR/Cas9-Based Cell Therapies in Immuno-Oncology– ZUG, Switzerland and […]
Potbelly Corporation Reports Results for Third Fiscal Quarter 2018
CHICAGO, Nov. 09, 2018 (GLOBE NEWSWIRE) — Potbelly Corporation (NASDAQ: PBPB) today reported financial results for the third fiscal quarter […]
BioXcel Therapeutics Reports Third Quarter 2018 Quarterly Results and Provides Business Update
NEW HAVEN, Conn., Nov. 09, 2018 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq: BTAI), a clinical stage biopharmaceutical development […]
Universal Stainless to Present at Southwest IDEAS Investor Conference on November 15th
Presentation to be Webcast and Archived BRIDGEVILLE, Pa., Nov. 09, 2018 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. […]
Axsome Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update
Final Phase 3 results of AXS-05 in treatment resistant depression now anticipated in 1Q 2019 Final Phase 2 results of […]
RISE Education Announces Management Change
BEIJING, Nov. 09, 2018 (GLOBE NEWSWIRE) — RISE Education Cayman Ltd (“RISE” or the “Company”) (NASDAQ: REDU), a leading junior […]
Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Progress
LOS ANGELES, Nov. 09, 2018 (GLOBE NEWSWIRE) — Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer […]
Reliv International Reports Third-Quarter Financial Results for 2018
CHESTERFIELD, Mo., Nov. 09, 2018 (GLOBE NEWSWIRE) — Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal […]
Neos Therapeutics Reports Third Quarter 2018 Financial Results
Company to host conference call today at 8:30am ET DALLAS and FORT WORTH, Texas, Nov. 09, 2018 (GLOBE NEWSWIRE) — […]
